Press Information
For Immediate release 1st October 2008
Senior International Management Appointment
ApaTech, the fast growing medical technology company, announces the appointment of Geert Hertecant as Vice President – OUS Region.
Prior to joining ApaTech, Geert was Regional Business Director, Spine and Biologics, North Europe for Medtronic. Geert started his medical device career with Medtronic in Belgium, becoming Business Manager of the Spine division and quadrupling sales in the period to 2005. Subsequently he joined Kyphon as Regional Director Europe North, but was reunited with Medtronic in 2007 upon the acquisition of Kyphon.
Simon Cartmell, CEO of ApaTech commented: “It is a tribute to our ambition, our technology and ApaTech’s undoubted potential, that we have attracted such a proven executive. Geert brings a strong track record of successfully launching and growing new products across Europe”
Geert Hertecant added: “I have been impressed with what ApaTech has achieved but, more importantly, the potential the company has. ApaTech has a strong culture that focuses on excellence, customer needs and team work, which, coupled with its leading edge science, gives me confidence that ApaTech will meet its ambitious objectives”
ApaTech expects to appoint further Area Directors for Southern Europe, Latin America and Asia Pacific before the end of 2008.
Ends
Further Information:
ApaTech +44 (0)20 8731 4640
Simon Cartmell, CEO
simon.cartmell@apatech.com
Waughton +44 (0)20 7796 9999
Robin Hepburn
rhepburn@waughton.com
Notes to Editors:
About ApaTech
ApaTech specialises in producing synthetic bone repair material. It has operations in London, England, Foxborough, USA, and Berlin, Germany, and is a world leader in bone graft technologies, selling its products in 21 countries around the world.
The Company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse™, which underpins the Company’s leadership in applying the science of silicon to bone graft technologies. The Company believes that Actifuse™ is the first of a new class of synthetic bone graft materials that combine osteoconductive and osteo-stimulatory activities.
ApaTech is backed by international investors, 3i and Healthcor and was recognized as Britain’s fastest growing medical technology company in both the 2008 and 2007 Sunday Times Fast Track 100 fastest growing private companies review.
More details can be found at www.apatech.com
